Abstract
There is controversy of whether prophylaxis treatment or a ''screen and treat'' policy should be adopted for preventing infective complications when women undergo abortion. There is currently compelling evidence that indicates that a universal policy of prophylaxis treatment to all women undergoing abortion should receive antibiotics. It is also a cost-effective policy.
| Original language | English |
|---|---|
| Pages (from-to) | 191-3 |
| Number of pages | 3 |
| Journal | The European Journal of Contraception and Reproductive Health Care |
| Volume | 12 |
| DOIs | |
| Publication status | Published - 1 Jan 2007 |